144 ·Filed Sep 2, 2026

TDOC

Teladoc Health, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago SEC0001959173-26-006651
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale related to equity vesting and likely tax withholding. The small size relative to market cap suggests no significant negative signal. Monitor for any subsequent Form 4 filings to see if the sale actually executes and whether other insiders follow suit.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
TDOC ▼ -12.23% at T+20d
NEUTRAL call ✗ call lost -12.23% · α vs SPY -12.08% · entry $6.46 → $5.67
Next anchor: T+60d in 8w
Entry anchored
Sep 2, 03:37 PM ET
via 1-min bar
T+1d
+0.15%
call +0.15% · α -0.89%
$6.47
settled 4w ago
T+5d
-5.73%
call -5.73% · α -4.77%
$6.09
settled 23d ago
T+20d
-12.23%
call -12.23% · α -12.08%
$5.67
settled yesterday
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Director Charles Divita III filed a Form 144 to sell 18,327 shares of Teladoc Health, Inc. at an estimated value of $115,484. The shares were acquired via restricted stock vesting. This is a routine insider selling notice, and historical performance data shows past neutral reports on TDOC have been followed by positive returns, but this filing itself does not carry strong directional signal.

Key Facts

  • Director Charles Divita III filed Form 144 to sell 18,327 shares of TDOC.
  • Estimated aggregate sale value is $115,483.92.
  • Shares were acquired on 09/01/2026 via restricted stock vesting.
  • Sale is to be executed through Fidelity Brokerage Services LLC.
  • Filing date is 09/02/2026; sale intended on or after that date.
  • Previous similar sale on 06/11/2026 was to cover tax obligations from equity award settlement.

Financial Impact

Proceeds from sale are approximately $115,484, which is small relative to TDOC's $1.1B market cap and the insider's likely total holdings.

dilution

Risk Factors

  • Continued insider selling could indicate lack of confidence, though this single filing is routine and small.
  • Teladoc's business fundamentals remain challenged with a $1.1B market cap and mostly Hold analyst consensus.

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
35% bullish (31 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-006651
Document: 0001959173-26-006651-index.html0001959173-26-006651
Document: 0001959173-26-006651.txt0001959173-26-006651
17 reports for TDOC
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +11.92%Aug 7, 2026
Filters
Rows
Reports for TDOC — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
144
NEUTRAL ★ 2/10
$6.16 $6.30▲ +2.27%▲ +2.49%$5.52 (−10.39%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$6.28 $6.50▲ +3.50%▲ +4.71%$5.52 (−12.10%)
Sep 2, 2026
4w ago
144
NEUTRAL ★ 2/10
$6.46 $6.09▼ −5.73%▼ −4.77%$5.52 (−14.55%)
Aug 7, 2026
8w ago
Press Release
BEARISH ★ 8/10
$7.13 $6.81▲ +4.49%▲ +4.89%$5.52 (+22.58%)
Jul 31, 2026
9w ago
Press Release
BEARISH ★ 8/10
$6.68 $7.08▼ −5.99%▼ −3.96%$5.52 (+17.37%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 2/10
$8.69 $9.29▲ +6.90%▲ +5.52%$5.52 (−36.48%)
Jun 11, 2026
16w ago
144
NEUTRAL ★ 2/10
$7.31 $7.59▲ +3.83%▲ +3.40%$5.52 (−24.49%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$7.31 $7.59▲ +3.83%▲ +3.40%$5.52 (−24.49%)
Jun 2, 2026
17w ago
144
NEUTRAL ★ 2/10
$7.09 $7.03▼ −0.85%▲ +2.97%$5.52 (−22.14%)
Jun 2, 2026
17w ago
144
NEUTRAL ★ 2/10
$7.09 $7.03▼ −0.85%▲ +2.97%$5.52 (−22.14%)
Showing 10 of 17

US Market Status

Market Closed — Opens Mon (35h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access